You’ll need to purchase needles to use Lantus SoloStar or Levemir FlexTouch prefilled pens. Both Levemir and Lantus are brand-name drugs. There’s a biosimilar available for Lantus, but not for ...

Both studies used pens filled with respective insulin brands, namely Levemir for the FlexPen and Lantus for the SoloSTAR.

Sanofi lost its appeals court bid to revive patents on its blockbuster Lantus SoloStar insulin injection pen in a victory for drugmaker Viatris Inc. A review board was correct to invalidate five ...

The French drugmaker said Monday it settled a lawsuit over patents for Lantus SoloStar, its once-daily insulin in a pen-like injector. The settlement allows rivals Eli Lilly and Co. and German ...

A rare point of consensus following the midterm elections is that Americans are adamant about lowering drug prices. Bipartisan pledges to seek common ground on this vexing issue suggest we might ...

It showed that 96% of patients experienced significant treatment satisfaction upon switching to Lantus(R) SoloSTAR(R) from their previous treatment: Diabetes Treatment Satisfaction Questionnaire ...

Levemir and Lantus are both long-acting injectable insulins that can be used for long-term management of diabetes. Insulin is a hormone that is naturally produced in the body by the pancreas.

A recent survey of LANTUS(R) SoloSTAR(R) use in everyday clinicalpractice, involving more than 2000 people with diabetes (16% with manualdexterity problems and 15% with poor eyesight not corrected ...

Whereas this new case involves Merck’s vial presentation of these insulin glargine products, Sanofi-Aventis separately sued Merck this past September in the District of Delaware for allegedly ...

Sanofi is taking Merck & Co to court claiming that the firm has infringed 10 patents covering its best-selling insulin glargine products Lantus and Lantus SoloStar. Sanofi is taking Merck & Co to ...

Compared to the glargine group, patients on premix also showed significantly greater hypoglycemic fear from week 12 to study end (P<0.05). The goal of the second study[2], conducted with 220 type 1 ...